Laura Modica de Mohac

Ms. Laura Modica de Mohac

University of Palermo
+1
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2022 in The Journal of Medicine Access
Verified
Journal Article
Open access
JAJamee Ahmed
Jamee Ahmed
Laura Modica de MohacLaura Modica de Mohac
Laura Modica de Mohac
TMTim K Mackey
Tim K Mackey
BRBahijja Raimi-Abraham
Bahijja Raimi-Abraham
Simultaneous expansion of the Internet and increased globalisation of the pharmaceutical industry have meant medication can be accessed transnationally from both legal and illicit sources. This has coincided with the rise of substandard and falsified medicines (SFMs) online. These products fail to meet regulatory or quality standards and/or are constituted with substandard ingredients, causing undesired pharmacological effects, including possible injury and death. This review aimed to identify original research studies that examined characteristics of SFM online sales, attitudes towards purchasing medicines online and strategies to address this drug safety challenge. Keywords of ‘Substandard’ and ‘Falsified’/‘Counterfeit’ and ‘Medicines’/‘Drugs’ and ‘Online’/‘Internet’ were searched using Web of Knowledge and PubMed databases. Resulting literature, which satisfied the study’s inclusion criteria, was included in the review, and the findings from each paper were assessed. From an initial 185 literature articles, 7 were eligible according to the inclusion criteria to be reviewed. These articles identified studies testing SFMs purchased online, surveys of attitudes and knowledge about SFMs online, and website content analysis to detect illegal online sales. Challenges identified were lack of knowledge and awareness among consumers and physicians, in addition to the use of direct-to-consumer-advertising, via Internet platforms and social media, providing easy access to SFMs. Despite this, medicine authentication technology, website verification approaches and new detection methods were identified as potential solutions specific to online SFM sales. To address online sales of SFMs, more robust research, greater awareness/educational programmes, analytical detection methods and more stringent online global governance are required.

24 December 2018 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Laura Modica de MohacLaura Modica de Mohac
Laura Modica de Mohac
AKAlison Veronica Keating
Alison Veronica Keating
MPMaria De Fátima Pina
Maria De Fátima Pina
BRBahijja Raimi-Abraham
Bahijja Raimi-Abraham
Poor aqueous solubility (<0.1 mg/mL) affects a significant number of drugs currently on the market or under development. Several formulation strategies including salt formation, particle size reduction, and solid dispersion approaches have been employed with varied success. In this review, we focus primarily on the emerging trends in the generation of amorphous and micro/nano-crystalline solid dispersions using electrospinning to improve the dissolution rate and in turn the bioavailability of poorly water-soluble drugs. Electrospinning is a simple but versatile process that utilizes electrostatic forces to generate polymeric fibers and has been used for over 100 years to generate synthetic fibers. We discuss the various electrospinning studies and spinneret types that have been used to generate amorphous and crystalline solid dispersions.

1 June 2020 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
Laura Modica de MohacLaura Modica de Mohac
Laura Modica de Mohac
BRBahijja Raimi-Abraham
Bahijja Raimi-Abraham
RCRoberto Caruana
Roberto Caruana
GGGiammona Gaetano
Giammona Gaetano
MLMariano Licciardi
Mariano Licciardi

1 July 2016 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
Laura Modica de MohacLaura Modica de Mohac
Laura Modica de Mohac
MPMaria de Fátima Pina
Maria de Fátima Pina
BRBahijja Raimi-Abraham
Bahijja Raimi-Abraham
In this study, we evaluate the dissolution rate enhancement of solid microcrystalline dispersion (SMD) films of olanzapine (OLZ) formulated with four water-soluble polymers namely poly(N-vinylpyrrolidone) (PVP), poloxamer 188 (P188), poloxamer 407 (P407) and Soluplus(®) (SLP). Prepared formulations were characterised to determine particle size, morphology, hydrogen bonding interactions, thermal characteristics as well as in vitro dissolution studies conducted under sink conditions (pH 6.8). Particle size of OLZ in all formulations ranged between 42 and 58μm. Attenuated Total Reflectance Fourier Transform Infrared spectroscopy (ATR-FTIR), Differential Scanning Calorimetry (DSC) and Hot-Stage Microscopy (HSM) studies confirmed OLZ was well maintained in its crystalline state during the formulation process. In vitro dissolution studies showed immediate drug release from all formulation when compared to the drug alone. The greatest increase in in vitro dissolution rate was observed in formulations containing P188 most likely due to its enhanced hydrophilic and surfactant properties compared to the other agents used. Overall, this study successfully generated OLZ loaded SMD films with improved in vitro dissolution rates which is highly likely to result in improved oral bioavailability in vivo.

19 February 2020 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
Laura Modica de MohacLaura Modica de Mohac
Laura Modica de Mohac
RCRoberto Caruana
Roberto Caruana
Gennara CavallaroGennara Cavallaro
Gennara Cavallaro
GGGaetano Giammona
Gaetano Giammona
MLMariano LICCIARDI
Mariano LICCIARDI

11 December 2019 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SCSuet Li Chew
Suet Li Chew
Laura Modica de MohacLaura Modica de Mohac
Laura Modica de Mohac
BRBahijja Raimi-Abraham
Bahijja Raimi-Abraham
With the well-known advantages of additive manufacturing methods such as three-dimensional (3D) printing in drug delivery, it is disappointing that only one product has been successful in achieving regulatory approval in the past few years. Further research and development is required in this area to introduce more 3D printed products into the market. Our study investigates the potential of fixed dose combination solid dispersion drug products generated via 3D printing. Two model drugs—fluorescein sodium (FS) and 5-aminosalicyclic acid (5-ASA)—were impregnated onto a polyvinyl alcohol (PVA) filament, and the influence of solvent choice in optimal drug loading as well as other influences such as the physicochemical and mechanical properties of the resultant filaments were investigated prior to development of the resultant drug products. Key outcomes of this work included the improvement of filament drug loading by one- to threefold due to solvent choice on the basis of its polarity and the generation of a 3D-printed product confirmed to be a solid dispersion fixed dose combination with the two model drugs exhibiting favourable in vitro dissolution characteristics.